Details

NameSymbolSector
ASTRAZENECA PHARMA INDIA LIMITEDASTRAZENPharmaceuticals
Open
9248
High
9380
Low
9156
Close
9331
Volume
12069
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

3.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Astrazeneca Pharma India is  
None
Estimated Stoploss of Astrazeneca Pharma India is ₹  
9156
Astrazeneca Pharma India has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Astrazeneca Pharma India is  
Unpredictableℹ
. 

Trend

Astrazeneca Pharma India is in  
Sideways trendℹ
. 
Price of Astrazeneca Pharma India is  
Upℹ
 by  

5.13

%. 
Target
Buy @ 

8293.31

Sell @ 

9497.51

Current @ 

9331

Volume

The trade volumes of Astrazeneca Pharma India have become  
Deficientℹ
Though the volume trend for Astrazeneca Pharma India appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Astrazeneca Pharma India is  

Down

 by  

52.24

% 

Valuation

The current market price of Astrazeneca Pharma India is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 1518cr and total assets worth ₹ 1518cr, the balance sheet of Astrazeneca Pharma India is:  
Balancedℹ
. 
Cashflow
Astrazeneca Pharma India has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 30cr

. It is  
Upℹ
 by  

500

%. 

(*Mar 2025)

40.63% i.e. ₹ 65cr earned in operatingℹ
18.75% i.e. ₹ 30cr earned in investingℹ
40.63% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Astrazeneca Pharma India has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 5cr

. It is  
Downℹ
 by  

90.2

%. 

(*Mar 2024)

29.35% i.e. ₹ 27cr earned in operatingℹ
22.83% i.e. ₹ 21cr earned in investingℹ
47.83% i.e. ₹ 44cr spent in financingℹ
0% in otherℹ
Income
The income of Astrazeneca Pharma India is  

₹ 537cr

 and  

Profit

 is :  

₹ 55cr

(*Jun 2025)

Astrazeneca Pharma India Profit is down by:  

5.17

% and Income is Up by:  

8.27

% 

(*Jun 2025)

The income of Astrazeneca Pharma India is  

₹ 496cr

 and  

Profit

 is :  

₹ 58cr

(*Mar 2025)

Astrazeneca Pharma India Profit is up by:  

93.33

% and Income is Up by:  

10.71

% 

(*Mar 2025)

The income of Astrazeneca Pharma India is  

₹ 448cr

 and  

Profit

 is :  

₹ 30cr

(*Dec 2024)

Astrazeneca Pharma India Profit is down by:  

21.05

% and Income is Up by:  

7.69

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.